Tapewire

Nasdaq · USD

CYTK

CYTOKINETICS INC

Export transactions ↓
Tapewire entity
3528
SEC CIK
0001061983
Parsed reports
875

Last 12 months

Inside the activity.

0 purchase rows · 83 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202509
Jan 202603
Feb 202602
Mar 2026017
Apr 202608
May 202609
Jun 202608
Jul 202609
Aug 202604
Sep 202608
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 01, 2022 Filed Sep 1, 2022 23:17 UTC Exercise / conversionCommon Stock 4,582 $6.82 $31,249.24
Disclosure

SEC source: 0001127602-22-021932 · form4.xml · nonDerivative · entry 3

PARSHALL B LYNNE · CIK 0001073385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,296

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.

Read SEC document
September 01, 2022 Filed Sep 1, 2022 23:17 UTC Exercise / conversionCommon Stock 20,000 $9.45 $189,000.00
Disclosure

SEC source: 0001127602-22-021932 · form4.xml · nonDerivative · entry 2

PARSHALL B LYNNE · CIK 0001073385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,714

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.

Read SEC document
September 01, 2022 Filed Sep 1, 2022 23:17 UTC Exercise / conversionCommon Stock 5,714 $8.75 $49,997.50
Disclosure

SEC source: 0001127602-22-021932 · form4.xml · nonDerivative · entry 1

PARSHALL B LYNNE · CIK 0001073385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,714

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.

Read SEC document
September 01, 2022 Filed Sep 1, 2022 22:19 UTC Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 4,166 $0.00 Strike: $6.78 $0.00
Disclosure

SEC source: 0001127602-22-021922 · form4.xml · derivative · entry 3

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,166 shares

Expires 2023-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.

Read SEC document
September 01, 2022 Filed Sep 1, 2022 22:19 UTC SaleCommon Stock 4,166 $52.79 $219,923.14
Disclosure

SEC source: 0001127602-22-021922 · form4.xml · nonDerivative · entry 2

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,170

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.

Read SEC document
September 01, 2022 Filed Sep 1, 2022 22:19 UTC Exercise / conversionCommon Stock 4,166 $6.78 $28,245.48
Disclosure

SEC source: 0001127602-22-021922 · form4.xml · nonDerivative · entry 1

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,336

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.

Read SEC document
August 18, 2022 Filed Jan 3, 2023 21:01 UTC
Blum Robert IDirector · President & CEO
GiftCommon Stock 3,035 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-000117 · form5.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406,412

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:18 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001127602-22-021384 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:18 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $50.11 $501,100.00
Disclosure

SEC source: 0001127602-22-021384 · form4.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,124

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
August 17, 2022 Filed Aug 19, 2022 20:18 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001127602-22-021384 · form4.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
August 05, 2022 Filed Aug 8, 2022 20:01 UTC Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 11,428 $0.00 Strike: $8.75 $0.00
Disclosure

SEC source: 0001127602-22-020670 · form4.xml · derivative · entry 3

Kaye Edward M. MD · CIK 0001522780 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,428 shares

Expires 2028-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 12, 2021.

Read SEC document
August 05, 2022 Filed Aug 8, 2022 20:01 UTC SaleCommon Stock 11,428 $50.00 $571,400.00
Disclosure

SEC source: 0001127602-22-020670 · form4.xml · nonDerivative · entry 2

Kaye Edward M. MD · CIK 0001522780 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,576

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 12, 2021.

Read SEC document
August 05, 2022 Filed Aug 8, 2022 20:01 UTC Exercise / conversionCommon Stock 11,428 $8.75 $99,995.00
Disclosure

SEC source: 0001127602-22-020670 · form4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,004

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 12, 2021.

Read SEC document
August 01, 2022 Filed Aug 3, 2022 20:11 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001127602-22-020353 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
August 01, 2022 Filed Aug 3, 2022 20:11 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $41.26 $412,600.00
Disclosure

SEC source: 0001127602-22-020353 · form4.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,124

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
August 01, 2022 Filed Aug 3, 2022 20:11 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001127602-22-020353 · form4.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
July 18, 2022 Filed Jul 20, 2022 20:50 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001127602-22-019558 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
July 18, 2022 Filed Jul 20, 2022 20:50 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $40.49 $404,900.00
Disclosure

SEC source: 0001127602-22-019558 · form4.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,472

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
July 18, 2022 Filed Jul 20, 2022 20:50 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001127602-22-019558 · form4.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,472

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
July 14, 2022 Filed Jul 14, 2022 21:24 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 21,500 $0.00 Strike: $9.65 $0.00
Disclosure

SEC source: 0001127602-22-019304 · form4.xml · derivative · entry 3

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,013

Underlying: Common Stock · 21,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
July 14, 2022 Filed Jul 14, 2022 21:24 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 21,500 $43.43 $933,745.00
Disclosure

SEC source: 0001127602-22-019304 · form4.xml · nonDerivative · entry 2

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,346

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
July 14, 2022 Filed Jul 14, 2022 21:24 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionCommon Stock 21,500 $9.65 $207,475.00
Disclosure

SEC source: 0001127602-22-019304 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,846

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
July 06, 2022 Filed Jul 8, 2022 21:34 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001127602-22-019153 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
July 06, 2022 Filed Jul 8, 2022 21:34 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $44.38 $443,800.00
Disclosure

SEC source: 0001127602-22-019153 · form4.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,472

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
July 06, 2022 Filed Jul 8, 2022 21:34 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001127602-22-019153 · form4.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,472

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
July 01, 2022 Filed Jul 12, 2022 20:41 UTC GrantCommon Stock 137 $41.00 $5,617.00
Disclosure

SEC source: 0001127602-22-019243 · form4.xml · nonDerivative · entry 1

Wysenski Nancy · CIK 0001294596 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,286

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $41.00, representing the closing stock price of the Issuer's common stock on July 1, 2022.

Read SEC document
July 01, 2022 Filed Jul 12, 2022 20:37 UTC GrantCommon Stock 137 $41.00 $5,617.00
Disclosure

SEC source: 0001127602-22-019241 · form4.xml · nonDerivative · entry 1

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,170

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $41.00, representing the closing stock price of the Issuer's common stock on July 1, 2022.

Read SEC document
July 01, 2022 Filed Jul 12, 2022 20:32 UTC GrantCommon Stock 137 $41.00 $5,617.00
Disclosure

SEC source: 0001127602-22-019239 · form4.xml · nonDerivative · entry 1

SMITH SANDFORD D · CIK 0001243004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,170

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Share are fully vested from the moment of grant. Shares are issued at per share price of $41.00, representing the closing stock price of the Issuer's common stock on July 1, 2022.

Read SEC document
July 01, 2022 Filed Jul 12, 2022 20:22 UTC GrantCommon Stock 274 $41.00 $11,234.00
Disclosure

SEC source: 0001127602-22-019234 · form4.xml · nonDerivative · entry 1

Kaye Edward M. MD · CIK 0001522780 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,576

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $41.00, representing the closing stock price of Issuer's common stock on July 1, 2022.

Read SEC document
July 01, 2022 Filed Jul 12, 2022 20:16 UTC GrantCommon Stock 487 $41.00 $19,967.00
Disclosure

SEC source: 0001127602-22-019232 · form4.xml · nonDerivative · entry 1

HENDERSON JOHN T · CIK 0001226488 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,049

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $41.00, representing the closing stock price of the Issuer's common stock on July 1, 2022.

Read SEC document
July 01, 2022 Filed Jul 12, 2022 20:08 UTC
Bhanji MunaDirector
GrantCommon Stock 274 $41.00 $11,234.00
Disclosure

SEC source: 0001127602-22-019228 · form4.xml · nonDerivative · entry 1

Bhanji Muna · CIK 0001846905 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,811

F1 · kind: Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $41.00, representing the closing stock price of the Issuer's common stock on July 1, 2022.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:08 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001127602-22-017758 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:08 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $39.40 $394,000.00
Disclosure

SEC source: 0001127602-22-017758 · form4.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,472

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:08 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001127602-22-017758 · form4.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,472

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
June 09, 2022 Filed Jun 10, 2022 20:15 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 21,500 $0.00 Strike: $9.65 $0.00
Disclosure

SEC source: 0001127602-22-017235 · form4.xml · derivative · entry 3

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,513

Underlying: Common Stock · 21,500 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
June 09, 2022 Filed Jun 10, 2022 20:15 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 21,500 $40.62 $873,330.00
Disclosure

SEC source: 0001127602-22-017235 · form4.xml · nonDerivative · entry 2

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,346

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
June 09, 2022 Filed Jun 10, 2022 20:15 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionCommon Stock 21,500 $9.65 $207,475.00
Disclosure

SEC source: 0001127602-22-017235 · form4.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,846

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 20:08 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001127602-22-017038 · form4.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 20:08 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $41.23 $412,300.00
Disclosure

SEC source: 0001127602-22-017038 · form4.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,472

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 20:08 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001127602-22-017038 · form4.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,472

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
May 16, 2022 Filed May 18, 2022 20:33 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $7.96 $0.00
Disclosure

SEC source: 0001061983-22-000127 · edgardoc.xml · derivative · entry 5

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,208

Underlying: Common Stock · 10,000 shares

Expires 2025-02-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
May 16, 2022 Filed May 18, 2022 20:33 UTC
Blum Robert IDirector · President & CEO
SaleCommon Stock 10,000 $43.11 $431,065.00
Disclosure

SEC source: 0001061983-22-000127 · edgardoc.xml · nonDerivative · entry 2

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 409,124

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
May 16, 2022 Filed May 18, 2022 20:33 UTC
Blum Robert IDirector · President & CEO
Exercise / conversionCommon Stock 10,000 $7.96 $79,600.00
Disclosure

SEC source: 0001061983-22-000127 · edgardoc.xml · nonDerivative · entry 1

Blum Robert I · CIK 0001288859 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,124

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
May 12, 2022 Filed May 12, 2022 21:52 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionIncentive Stock Option (right to buy) · Derivative 13,987 $0.00 Strike: $9.65 $0.00
Disclosure

SEC source: 0001061983-22-000125 · edgardoc.xml · derivative · entry 3

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,987 shares

Expires 2024-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
May 12, 2022 Filed May 12, 2022 21:52 UTC
Malik Fady IbrahamEVP Research & Development
SaleCommon Stock 13,987 $37.54 $525,074.78
Disclosure

SEC source: 0001061983-22-000125 · edgardoc.xml · nonDerivative · entry 2

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,084

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
May 12, 2022 Filed May 12, 2022 21:52 UTC
Malik Fady IbrahamEVP Research & Development
Exercise / conversionCommon Stock 13,987 $9.65 $134,974.55
Disclosure

SEC source: 0001061983-22-000125 · edgardoc.xml · nonDerivative · entry 1

Malik Fady Ibraham · CIK 0001551778 · EVP Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,071

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021.

Read SEC document
May 10, 2022 Filed May 11, 2022 18:04 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $37.89 $0.00
Disclosure

SEC source: 0001061983-22-000116 · edgardoc.xml · derivative · entry 2

COSTA SANTO J · CIK 0001013419 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 18:04 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001061983-22-000116 · edgardoc.xml · nonDerivative · entry 1

COSTA SANTO J · CIK 0001013419 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · kind: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:06 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 10,000 $0.00 Strike: $37.89 $0.00
Disclosure

SEC source: 0001061983-22-000120 · edgardoc.xml · derivative · entry 2

PARSHALL B LYNNE · CIK 0001073385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-05-10

F2 · derivative.exercise_date: Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023.

Read SEC document
May 10, 2022 Filed May 11, 2022 22:06 UTC GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001061983-22-000120 · edgardoc.xml · nonDerivative · entry 1

PARSHALL B LYNNE · CIK 0001073385 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · kind: Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.